Parabolic Drugs reports standalone net loss of Rs 28.04 crore in the September 2014 quarter

Sales decline 56.43% to Rs 49.63 crore

Net Loss of Parabolic Drugs reported to Rs 28.04 crore in the quarter ended September 2014 as against net loss of Rs 22.32 crore during the previous quarter ended September 2013. Sales declined 56.43% to Rs 49.63 crore in the quarter ended September 2014 as against Rs 113.91 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales49.63113.91 -56 OPM %-9.313.75 -PBDT-23.31-15.32 -52 PBT-40.57-32.31 -26 NP-28.04-22.32 -26

Powered by Capital Market - Live News